Concepedia

Diana Cirstea

DC

36

Publications

4K

Citations

27

H-Index

2007

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Massachusetts General Hospital

Brigham and Women's Hospital

VA Boston Healthcare System

Diana Cirstea is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

2007–2024

36

Publications

36

Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma

Loredana Santo, Teru Hideshima, Andrew L. Kung et al. · Blood · 2012 · 594 citations · Full text

Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma

Naoya Mimura, Mariateresa Fulciniti, Güllü Görgün et al. · Blood · 2012 · 431 citations · Full text

A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma

Güllü Görgün, Elisabetta Calabrese, Teru Hideshima et al. · Blood · 2010 · 271 citations

Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease

Sonia Vallet, Siddhartha Mukherjee, Nileshwari Vaghela et al. · Proceedings of the National Academy of Sciences · 2010 · 232 citations · Full text

, , +15

Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma

Güllü Görgün, Elisabetta Calabrese, Ender Soydan et al. · Blood · 2010 · 228 citations · Full text

Rows per page

1–5 of 36